MMM
54
-3
HST
58
-4
KIM
51
-3
D
43
-2
JNJ
57
-3
FRT
58
-2
RL
75
-4
EXPD
35
-2
MDT
53
-2
DVA
49
-3
NKE
43
-5
BRK.B
43
-6
CCL
64
-4
NSC
59
-3
PX
62
6
ECL
52
-2
HRL
30
-5
MDLZ
22
-2
MCHP
45
-4
HUM
34
-8
MMM
54
-3
HST
58
-4
KIM
51
-3
D
43
-2
JNJ
57
-3
FRT
58
-2
RL
75
-4
EXPD
35
-2
MDT
53
-2
DVA
49
-3
NKE
43
-5
BRK.B
43
-6
CCL
64
-4
NSC
59
-3
PX
62
6
ECL
52
-2
HRL
30
-5
MDLZ
22
-2
MCHP
45
-4
HUM
34
-8
Financhill
Back

Entrée Resources Ltd. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
22

ERLFF
Entrée Resources Ltd.

Last Price:
$1.59
Seasonality Move:
-0.63%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Sell
22
Entrée Resources Ltd. (ERLFF) is a Sell

Is Entrée Resources Ltd. a Buy, Sell or Hold?

  • The current Entrée Resources Ltd. [ERLFF] share price is $1.61. The Score for ERLFF is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ERLFF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ERLFF Stock Price Chart

What is Entrée Resources Ltd.'s stock price today?

  • The Entrée Resources Ltd. share price today is $1.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ERLFF is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

ERLFF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 41.77 Sell
Chaikin Money Flow: -9243 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.61 - 1.69) Sell
Bollinger Bands (100): (1.55 - 1.69) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

ERLFF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.67 Sell
20-day SMA: 1.65 Sell
50-day SMA: 1.66 Sell
200-day SMA: 1.61 Buy
8-day EMA: 1.65 Sell
20-day EMA: 1.66 Sell
50-day EMA: 1.63 Sell
200-day EMA: 1.11 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Entrée Resources Ltd. Earnings Growth & ERLFF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Entrée Resources Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):